|
|
|
| Immunohistochemical Markers Combined with Tumor Necrosis Factor α The Clinical Significance of miRNA-107 in the Diagnosis of Gastric Cancer |
| Pan Zhiyu1, Gao Longtan2, Wang Ning3 |
1. Pathology Department of Xinzheng Public People's Hospital,Xinzheng 451100,Henan;
2. Department of General Surgery,Henan Tianyou Integrated Traditional Chinese and Western Medicine Cancer Hospital,Xinzheng 451100,Henan;
3. Department of Pathology,Zhengzhou Central Hospital Affiliated to Zhengzhou University,Zhengzhou,Henan 450000,China |
|
|
|
|
Abstract Objective To analyze the combination of immunohistochemistry indicators and tumor necrosis factor α、 The clinical value of miRNA-107 in the diagnosis of gastric cancer. Method 48 gastric cancer patients（gastric cancer group）admitted to the hospital were included in the study.In addition,48 benign gastric cancer patients（benign gastric cancer group）and 48 healthy individuals（healthy group）who visited the hospital during the same period were selected.Immunohistochemical indicators and tumor necrosis factor tests were performed on all tested subjects- α And miRNA-107 testing.Subsequently,based on the degree of disease progression of gastric cancer patients,the gastric cancer group was divided into an early group（n=22）and an advanced group（n=26）.The immunohistochemical index test and tumor necrosis factor were compared between the two groups of patients- α Tumor crossing factor- α,TNF- α）And miRNA-107 test,receiver operating characteristic（ROC）analysis of immunohistochemical indicators,tumor necrosis factor- α And the diagnostic value of miRNA-107 test in gastric cancer disease. Result In the gastric cancer group,the human epidermal growth factor was regulated by -2（Her-2）and TNF- α、 MiRNA-107 was higher than the other two groups（P<0.05）.Compared with the early group,Her-2 and TNF in patients in the advanced group- α And miRNA-107 levels were higher,with significant differences（P<0.05）.Joint testing has the highest diagnostic value in the diagnosis,differential diagnosis of benign and malignant gastric cancer,and evaluation of gastric cancer progression.Its Area Under Curve（AUC）values are 0.949,0.997,and 1.000,respectively. Conclusion Her-2,TNF- α The increase in miRNA-107 levels is closely related to the severity of gastric cancer,and the combined detection of this indicator is of great significance in clarifying the diagnosis,malignancy,and progression of gastric cancer.
|
|
Received: 12 February 2025
|
|
|
|
|
|
[1] 金洋冰,蔡劬,计骏,等.抗体偶联药物维迪西妥单抗对HER-2不同表达水平胃癌细胞抑制效应的体外研究[J].临床肿瘤学杂志,2023,28(1):1-7.
[2] 郭艳绒,石蕾.胃癌组织中FBXO45和SKP1蛋白表达及其临床预后意义[J].药物生物技术,2020,27(1):47-51.
[3] 彭柳航. 血清载脂蛋白CⅠ、载脂蛋白CⅢ的检测在胃癌早期诊断中的应用价值分析[J].药物生物技术,2019,26(6):502-504.
[4] 张雪,赵丽丽,闫文娴,等.HER-2对胃癌细胞生物学行为及EMT、Wnt通路的影响[J].临床肿瘤学杂志,2023,28(7):585-591.
[5] 刘晓瑜,林翠君,黄洁,等.联合超声、MRI及钼靶评估HER-2过表达型及三阴性乳腺癌的诊断价值研究[J].临床放射学杂志,2023,42(7):1098-1102.
[6] 李剑锋,蒋军林.miRNA-107、肿瘤坏死因子α及血清胃蛋白酶原Ⅰ/Ⅱ联合检查对胃癌的诊断价值[J].国际老年医学杂志,2023,44(5):597-600.
[7] 杨秀春,王盼,余涛,等.miRNA-107在胃癌、结直肠癌及其癌前病变中的表达水平及临床意义[J].中国中西医结合消化杂志,2020,28(1):52-57.
[8] 罗文,王伟宁,彭进,等.基于Wnt/β-catenin信号通路探究过表达miR-124对胃癌前病变模型大鼠的干预效果[J].解放军医学院学报,2023,44(4):396-400.
[9] 戚利坤,王巍.肿瘤坏死因子α诱导蛋白6在胃癌组织中的表达及其与预后的关系[J].天津医药,2022,50(3):300-304.
[10] 薛满,雷海锋,刘安选.腹腔镜胃癌根治术对胃癌患者血清血红素加氧酶-1和肿瘤坏死因子-α及C反应蛋白的影响[J].中国肿瘤临床与康复,2019,26(5):551-554. |
| [1] |
. [J]. journal1, 2024, 44(4): 88-90. |
| [2] |
. [J]. journal1, 2024, 44(2): 77-78. |
| [3] |
Xia Xinguang. The Value of Real-time Ultrasound Elastography Combined with Color Doppler Ultrasound in the Differential Diagnosis of Benign and Malignant Cervical Space-occupying Lesions[J]. journal1, 2023, 43(4): 32-34. |
| [4] |
. [J]. journal1, 2023, 43(4): 108-109. |
| [5] |
. [J]. journal1, 2023, 43(4): 101-102. |
| [6] |
. [J]. journal1, 2023, 43(4): 115-116. |
|
|
|
|
2025, Vol. 45 
